Lacosamid Mylan (Lacosamide)

Lacosamide works by enhancing the slow inactivation of voltage‑gated sodium channels in neuronal membranes, which stabilizes hyper‑excitable neurons and reduces the likelihood of seizure firing. It may also interact with the CRMP2 protein, further modulating neuronal excitability and contributing to its anticonvulsant properties.

The specific dose of Lacosamid Mylan is determined by the prescribing clinician based on the individual’s age, weight, renal function, and response to therapy. Typically, treatment starts with a low dose that is gradually increased to achieve optimal seizure control while minimizing side effects.

Safety data for lacosamide in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Lacosamid Mylan. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Lacosamide offers a distinct mechanism by enhancing slow sodium‑channel inactivation, unlike many older agents that target fast inactivation. Compared with drugs such as carbamazepine or phenytoin, lacosamide may have a lower risk of certain drug‑enzyme interactions and a different side‑effect profile, making it a useful alternative for patients who do not tolerate or respond to traditional sodium‑channel blockers.

Lacosamid Mylan should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity, which could affect its stability.

Lacosamid Mylan is taken orally, usually as a tablet or capsule, with or without food as directed by the prescriber. The medication should be swallowed whole with a glass of water and taken at the same times each day to maintain consistent blood levels.

Serious risks include the potential for suicidal thoughts or behavior, severe skin reactions such as Stevens‑Johnson syndrome, cardiac conduction abnormalities like PR‑interval prolongation, and rare cases of severe allergic reactions or liver injury. Patients should be monitored closely for any new or worsening symptoms and seek immediate medical attention if serious adverse events occur.

Lacosamid Mylan is contraindicated in individuals with known hypersensitivity to lacosamide or any of its excipients. Caution is advised for patients with significant cardiac conduction disorders, severe renal impairment, or those taking medications that markedly prolong the PR interval. Pregnant or breastfeeding women should only use it when clearly indicated by a healthcare professional.